Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Monte Rosa Therapeutics (GLUE) Other Gross PP&E Adjustments (2023 - 2025)

Monte Rosa Therapeutics' Other Gross PP&E Adjustments history spans 3 years, with the latest figure at $29.2 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 26.92% year-over-year to $29.2 million; the TTM value through Dec 2025 reached $29.2 million, up 26.92%, while the annual FY2025 figure was $29.2 million, 26.92% up from the prior year.
  • Other Gross PP&E Adjustments reached $29.2 million in Q4 2025 per GLUE's latest filing, up from $28.1 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $29.2 million in Q4 2025 to a low of $13.5 million in Q2 2023.
  • Average Other Gross PP&E Adjustments over 3 years is $21.5 million, with a median of $22.0 million recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 59.21% in 2024, then rose 23.4% in 2025.
  • A 3-year view of Other Gross PP&E Adjustments shows it stood at $17.2 million in 2023, then skyrocketed by 33.51% to $23.0 million in 2024, then rose by 26.92% to $29.2 million in 2025.
  • Per Business Quant, the three most recent readings for GLUE's Other Gross PP&E Adjustments are $29.2 million (Q4 2025), $28.1 million (Q3 2025), and $26.8 million (Q2 2025).